Structure–activity relationship studies of Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma

• DOI: 10.1016/j.ejmech.2024.117047
• Publication Date: 2024-11-12T20:15:51Z
• Authors: Jisook Kim; Seung Hyun Jung; Joo Chan Lee; Won Jeoung Kim; Jooyun Byun; Young Gil Ahn; Hyun-Ju Park